China-headquartered VivaVision Biotech is looking to advance its non-steroidal therapy, VVN461-CS-201 (VVN461), in a Phase III trial after the candidate met the primary endpoint in a Phase II US ...
A literature search was performed to determine whether non-steroidal anti-inflammatory drugs (NSAIDs) adversely affect the healing of stress fractures. Evidence exists from laboratory studies and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback